YU49427B - Mikročestice derivata tetrahidropiridina - Google Patents

Mikročestice derivata tetrahidropiridina

Info

Publication number
YU49427B
YU49427B YU28899A YU28899A YU49427B YU 49427 B YU49427 B YU 49427B YU 28899 A YU28899 A YU 28899A YU 28899 A YU28899 A YU 28899A YU 49427 B YU49427 B YU 49427B
Authority
YU
Yugoslavia
Prior art keywords
microparticles
tetrahydropyridin
derivatives
dependent
50vμm
Prior art date
Application number
YU28899A
Other languages
English (en)
Other versions
YU28899A (sh
Inventor
Antoine Caron
Jean-Pierre Chambon
Olivier Monnier
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of YU28899A publication Critical patent/YU28899A/sh
Publication of YU49427B publication Critical patent/YU49427B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Abstract

Mikročestice 1-[2-(2-naftil)etil]-4-(3-trifluorometilfenil)-1,2,3,6-tetrahidropiridin hidrohlorida, naznačen time, što se sastoji od čestica od kojih najmanje 55% ima prečnik manji od 50Вµm. Prijava sadrži još 6 zavisnih patentnih zahteva, 1 nezavisan patentni zahtev i 1 zavisan patentni zahtev.
YU28899A 1996-12-23 1997-12-23 Mikročestice derivata tetrahidropiridina YU49427B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615905A FR2757510B1 (fr) 1996-12-23 1996-12-23 Forme microparticulaire d'un derive de tetrahydropyridine

Publications (2)

Publication Number Publication Date
YU28899A YU28899A (sh) 2000-03-21
YU49427B true YU49427B (sh) 2006-01-16

Family

ID=9499044

Family Applications (1)

Application Number Title Priority Date Filing Date
YU28899A YU49427B (sh) 1996-12-23 1997-12-23 Mikročestice derivata tetrahidropiridina

Country Status (38)

Country Link
US (4) US20020028247A1 (sh)
EP (1) EP0950051B1 (sh)
JP (2) JP4422214B2 (sh)
KR (1) KR100455797B1 (sh)
CN (1) CN1088698C (sh)
AR (1) AR009673A1 (sh)
AT (1) ATE250032T1 (sh)
AU (1) AU730302B2 (sh)
BR (1) BR9714177A (sh)
CA (1) CA2275593C (sh)
CO (1) CO4920213A1 (sh)
CZ (1) CZ294272B6 (sh)
DE (1) DE69724999T2 (sh)
DK (1) DK0950051T3 (sh)
DZ (1) DZ2386A1 (sh)
EE (1) EE04112B1 (sh)
EG (1) EG24749A (sh)
ES (1) ES2207758T3 (sh)
FR (1) FR2757510B1 (sh)
HK (1) HK1024000A1 (sh)
HU (1) HU224348B1 (sh)
IL (1) IL129937A (sh)
IN (1) IN186977B (sh)
IS (1) IS2064B (sh)
MY (1) MY126298A (sh)
NO (1) NO311569B1 (sh)
NZ (1) NZ336129A (sh)
PL (1) PL190098B1 (sh)
PT (1) PT950051E (sh)
RU (1) RU2193031C2 (sh)
SI (1) SI0950051T1 (sh)
SK (1) SK283917B6 (sh)
TR (1) TR199901362T2 (sh)
TW (1) TW534820B (sh)
UA (1) UA66776C2 (sh)
WO (1) WO1998028272A1 (sh)
YU (1) YU49427B (sh)
ZA (1) ZA9711579B (sh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4570357B2 (ja) * 2001-07-06 2010-10-27 ライフサイクル ファーマ エー／エス 制御された凝集
BE1015641A4 (fr) * 2003-05-26 2005-07-05 Mariani Jean Paul Micronisation 70.
RU2472490C1 (ru) * 2011-08-05 2013-01-20 Открытое акционерное общество "Биосинтез" Средство для лечения кожных гнойных инфекций, составы и способы получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US562883A (en) * 1896-06-30 Thill-coupling
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
US4826689A (en) * 1984-05-21 1989-05-02 University Of Rochester Method for making uniformly sized particles from water-insoluble organic compounds
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2639226B1 (fr) * 1988-11-18 1993-11-05 Sanofi Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
CA2126685C (en) * 1992-10-26 2002-07-23 Bruno Gander Process for the production of microcapsules
US5662883A (en) * 1995-01-10 1997-09-02 Nanosystems L.L.C. Microprecipitation of micro-nanoparticulate pharmaceutical agents
US5560932A (en) * 1995-01-10 1996-10-01 Nano Systems L.L.C. Microprecipitation of nanoparticulate pharmaceutical agents
US6489334B2 (en) * 1996-12-23 2002-12-03 Sanofi-Synthelabo Method for the crystallization of a tetrahydropyridin derivative and resulting crystalline forms
FR2763847B1 (fr) * 1997-05-28 2003-06-06 Sanofi Sa Utilisation de tetrahydropyridines 4-substituees pour fabriquer des medicaments agissant sur le tgf-beta-1
US20020147216A1 (en) * 2000-01-31 2002-10-10 Yuhong Zhou Mucin synthesis inhibitors

Also Published As

Publication number Publication date
SI0950051T1 (en) 2004-02-29
JP2001507013A (ja) 2001-05-29
CN1088698C (zh) 2002-08-07
DE69724999T2 (de) 2004-07-22
IL129937A0 (en) 2000-02-29
CO4920213A1 (es) 2000-05-29
HU224348B1 (hu) 2005-08-29
HK1024000A1 (en) 2000-09-29
YU28899A (sh) 2000-03-21
CZ229199A3 (cs) 1999-09-15
AR009673A1 (es) 2000-04-26
DK0950051T3 (da) 2004-01-26
NO311569B1 (no) 2001-12-10
RU2193031C2 (ru) 2002-11-20
JP2009280581A (ja) 2009-12-03
TR199901362T2 (xx) 1999-09-21
US20020192292A1 (en) 2002-12-19
CN1241179A (zh) 2000-01-12
EE04112B1 (et) 2003-08-15
ES2207758T3 (es) 2004-06-01
NO993077D0 (no) 1999-06-22
FR2757510B1 (fr) 2000-01-07
EE9900263A (et) 2000-02-15
HUP0001181A2 (hu) 2000-11-28
DZ2386A1 (fr) 2002-12-28
EP0950051B1 (fr) 2003-09-17
ATE250032T1 (de) 2003-10-15
KR20000069503A (ko) 2000-11-25
CA2275593C (en) 2005-12-20
IN186977B (sh) 2001-12-22
BR9714177A (pt) 2000-02-29
CZ294272B6 (cs) 2004-11-10
US20020028247A1 (en) 2002-03-07
JP4422214B2 (ja) 2010-02-24
PL190098B1 (pl) 2005-10-31
TW534820B (en) 2003-06-01
DE69724999D1 (de) 2003-10-23
KR100455797B1 (ko) 2004-11-06
SK82999A3 (en) 1999-12-10
PL334276A1 (en) 2000-02-14
ZA9711579B (en) 1998-06-25
PT950051E (pt) 2004-02-27
UA66776C2 (uk) 2004-06-15
EP0950051A1 (fr) 1999-10-20
US20100021541A1 (en) 2010-01-28
IL129937A (en) 2002-09-12
AU730302B2 (en) 2001-03-01
WO1998028272A1 (fr) 1998-07-02
US20080255365A1 (en) 2008-10-16
SK283917B6 (sk) 2004-05-04
CA2275593A1 (en) 1998-07-02
FR2757510A1 (fr) 1998-06-26
IS5077A (is) 1999-06-10
AU5668598A (en) 1998-07-17
IS2064B (is) 2005-11-15
NO993077L (no) 1999-06-22
HUP0001181A3 (en) 2003-03-28
MY126298A (en) 2006-09-29
NZ336129A (en) 2000-11-24
EG24749A (en) 2010-07-20

Similar Documents

Publication Publication Date Title
CY1108348T1 (el) Υποκατεστημενα 2-(2,6-διοξοπιπεριδιν-3-υλ)-φθαλιμιδια και μεθοδος μειωσης των tnf αλφα επιπεδων
PA8475601A1 (es) Formulaciones de ziprasidona
BR9607347A (pt) Esteres e amidas de 1,4-piperidina dissubstítuída possuindo atividade antagonística 5-ht
EE9600186A (et) Neurokiniini (tahhüülkiniini) antagonistid
DE60029857D1 (de) Lichtempfindliche Zusammensetzung und 1,3-dihydro-1-oxo-2H-Indenderivat
YU15299A (sh) Farmaceutski sastavi
NO972526D0 (no) Tachykininantagonister
PL350427A1 (en) Phenyl− and pyridinyl derivatives as neurokinin 1 antagonists
DE69531331D1 (de) Phenylpiperidinderivate als neurokinin antagonists
EP1567161A4 (en) PHARMACEUTICAL COMPOSITION OF 1- (3,4-DIMETHOXYPHENYL) -4-METHYL-5-ETHYL-7-METHOXY-8-HYDROXY-5H-2,3-BENZODIAZEPINE AND ITS USE
ATE301329T1 (de) Partikel
HUP9904167A3 (en) 1,4-disubstituted piperazine and piperidine derivatives, their use and pharmaceutical compositions containing the same
EP0952154A3 (en) N-acyl and N-aroyl aralkyl amides
YU49427B (sh) Mikročestice derivata tetrahidropiridina
DE69511323D1 (de) Emulsionspolymerisationsinhibitor und Suspensionspolymerisationsverfahren, die diesen Verwenden
PT811593E (pt) Agentes insecticidas e acaricidas 1,4-diaril-2-fluor-2-buteno
ID15912A (id) Turunan-turunan 1-(1,2-piperidinil yang didwisubstitusi)-4-(imidazol yang dilebur)-piperidin
EP1144402A3 (en) Substituted oximes and hydrazones as neurokinin antagonists
PL331882A1 (en) Substituted 1,2,3,4-tetrahydro-2-dibenzofurane amines and 2-amino cyclohepta[b]benzofuranes
DK1315700T3 (da) Substituerede 4-phenyl-1-(1-phenylcyclohexyl)-1,2,3,6-tetrahydropyridiner
EP0828493A4 (en) 4.4-DISUBSTITUTED CYCLOHEXANE-1-OL MONOMERS AND RELATED COMPOUNDS
DE69509361T2 (de) Polyetherglyole und alkohole aus 3,4-epoxy-1-butenen
DE69422496T2 (de) Mittel gegen malaria
TR200402036T4 (tr) (-)-Cis-2-(2-Klorofenil)-5, 7-Dihidroksi-8-[4R-(3S-Hidroksi-1-Metil) Piperidinil]-4H-1- Benzopiran-4-on'un psödopolimorfu
DE69928017D1 (de) Superfeines wolframteilchen und verfahren zu dessen herstellung